David Helfrich MD in Bethel Park, Pennsylvania

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Pittsburgh School Of Medicine
Graduation Year: 1983
The Primary Medical Specialty for David Helfrich MD is listed as: Rheumatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 41
PAC (PECOS ID)#: 7416984885
NPI #: 1770565095
NPI Created On: 11/14/2005
NPI Last Updated Listed as: 04/06/2021
Primary Taxonomy Code: 174400000X
License Number:
MD031457E
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Highmark Health Insurance Company
• Humana
• Highmark Inc.
• UPMC Health Options, Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
4. Infusion of chemotherapy into a vein up to 1 hour
5. Infusion of chemotherapy into a vein
6. New patient office or other outpatient visit, typically 30 minutes
7. New patient office or other outpatient visit, typically 45 minutes
8. Established patient office or other outpatient visit, typically 10 minutes
9. Established patient office or other outpatient visit, typically 15 minutes
10. Established patient office or other outpatient, visit typically 25 minutes
11. Physician telephone patient service, 5-10 minutes of medical discussion
12. Physician telephone patient service, 11-20 minutes of medical discussion
13. Physician telephone patient service, 21-30 minutes of medical discussion
14. Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
15. Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
16. Injection, denosumab, 1 mg
17. Injection, methylprednisolone acetate, 20 mg
18. Injection, methylprednisolone acetate, 40 mg
19. Injection, infliximab, excludes biosimilar, 10 mg
20. Injection, zoledronic acid, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).